Clinical Trial Update: Rituximab + High-Dose Methylprednisolone Debulking Prior to Venetoclax for CLL & SLL Patients [Phase 1]

View source ↗

Summary

Phase 1 study assessing rituximab plus high-dose methylprednisolone debulking before venetoclax in patients with chronic lymphocytic leukemia or small lymphocyt…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Small Lymphocytic Lymphoma

Drugs mentioned

• METHYLPREDNISOLONE (methylprednisolone)
• Rituximab (rituximab)
• Venetoclax (venetoclax)

Snippet

Sponsor: University of California, San Diego | Conditions: Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-10-15